Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Other Non-Current Liabilities of $3489.0 for Q1 2026, down 53.98% on a YoY basis from $7582.0 in Q1 2025, and down 23.15% sequentially from $4540.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 6 years of Other Non-Current Liabilities data on file, last reported at $3489.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 53.98% year-over-year to $3489.0; the trailing twelve-month figure through Mar 2026 stood at $3489.0 (down 53.98% YoY), and the FY2025 full-year result was $4540.0, down 47.01% from the prior year.
- Other Non-Current Liabilities declined to $3489.0 in Q1 2026, from $4540.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $15823.0 in Q4 2022 to a low of $3489.0 in Q1 2026.
- A 5-year average of $10240.8 and a median of $10477.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities dropped 14.27% in 2023 and tumbled 53.98% in 2026, its largest moves.
- Tracing BJDX's Other Non-Current Liabilities over 5 years: stood at $15823.0 in 2022, then dropped by 22.13% to $12321.0 in 2023, then sank by 30.47% to $8567.0 in 2024, then sank by 47.01% to $4540.0 in 2025, then fell by 23.15% to $3489.0 in 2026.
- Business Quant data shows BJDX's Other Non-Current Liabilities at $3489.0 in Q1 2026, $4540.0 in Q4 2025, and $5573.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,489.00 |
| Dec 31, 2025 | 4,540.00 |
| Sep 30, 2025 | 5,573.00 |
| Jun 30, 2025 | 6,589.00 |
| Mar 31, 2025 | 7,582.00 |
| Dec 31, 2024 | 8,567.00 |
| Sep 30, 2024 | 9,530.00 |
| Jun 30, 2024 | 10,477.00 |
| Mar 31, 2024 | 11,407.00 |
| Dec 31, 2023 | 12,321.00 |
| Sep 30, 2023 | 13,220.00 |
| Jun 30, 2023 | 14,104.00 |
| Mar 31, 2023 | 14,970.00 |
| Dec 31, 2022 | 15,823.00 |
| Sep 30, 2022 | 15,420.00 |
| Dec 31, 2020 | 155,629.00 |